These recordings of an August 1, 2020, livestream event provide information on the treatment of hospitalized patients with severe or life-threatening COVID-19. Topics covered include the history and evolution of convalescent plasma therapies; implementation of the ongoing expanded access program for COVID-19 patients; current data; blood bank and donor recruitment strategies; and world perspectives on treatment of COVID-19 patients with plasma.
|August 1, 2020 Livestream Recordings|
|Welcome & Introduction|
R.Scott Wright, M.D., Mayo Clinic, Minnesota
|History of Convalescent Plasma|
Arturo Casadevall, M.D., Ph.D., Johns Hopkins
|Thoughts on the Design and Background of EAP from the US FDA|
Peter Marks, M.D., Ph.D, Food and Drug Administration
|Update on EAP – Safety Data and Enrollment|
Michael J. Joyner, M.D., Mayo Clinic, Minnesota
Arturo Casadevall, M.D., Ph.D., Peter Marks, M.D., Rickey Carter, Ph.D. and Liise-anne Pirofski, M.D.
Moderators: R. Scott Wright, M.D. & C. Scott Collins, M.D.
|Organization of the Team and Data, How it was Done|
Jonathon (Jack) Senefeld, Ph.D., Mayo Clinic, Minnesota
Katelyn A. Bruno, Ph.D., Mayo Clinic, Florida
|Blood Bank/Donor Recruitment|
Camille van Buskirk, M.D., Mayo Clinic, Minnesota
Kathryn F. Larson, M.D., Mayo Clinic, Minnesota
Rickey E. Carter, Ph.D., Mayo Clinic, Florida
DeLisa Fairweather, Ph.D., Mayo Clinic Florida
Hiba Saud AlHumaidan, M.D., Sheikh Khalifa Medical City, Abu Dhabi, UAE
|The Landscape of Apps and AI’s for COVID Tracking|
Suraj Kapa, M.D., Mayo Clinic, Minnesota